Insider Transactions in Q2 2023 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 31
2023
|
Senthil Vel Sundaram Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,111
+17.77%
|
$2,111
$1.41 P/Share
|
May 31
2023
|
Seokho Bryan Yoon COO and General Counsel |
BUY
Open market or private purchase
|
Direct |
9,997
+36.15%
|
$9,997
$1.41 P/Share
|
May 31
2023
|
Mark J. Vignola Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,997
+36.15%
|
$9,997
$1.41 P/Share
|